相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease
Shun He et al.
NATURE (2019)
Roles for endothelial cell and macrophage Gch1 and tetrahydrobiopterin in atherosclerosis progression
Gillian Douglas et al.
CARDIOVASCULAR RESEARCH (2018)
Sex differences in the vascular function and related mechanisms: role of 17 beta-estradiol
Mallikarjuna R. Pabbidi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Endothelial-Specific Cre Mouse Models: Is Your Cre CREdibile?
Sophie Payne et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice
Sebastian Steven et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
Michael A. Nauck et al.
CIRCULATION (2017)
Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2
Sven Jaeckel et al.
BLOOD (2017)
The Cardiovascular Biology of Glucagon-like Peptide-1
Daniel J. Drucker
CELL METABOLISM (2016)
Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance
Gemma Pujadas et al.
ENDOCRINE REVIEWS (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gliptin and GLP-1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide-induced endotoxemia
Sebastian Steven et al.
BASIC RESEARCH IN CARDIOLOGY (2015)
Inflammation and Immunity in Diseases of the Arterial Tree Players and Layers
Peter Libby et al.
CIRCULATION RESEARCH (2015)
Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow
Elisa P. Jensen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics
Kamil Kus et al.
DRUG METABOLISM AND DISPOSITION (2015)
Molecular Mechanisms of the Crosstalk Between Mitochondria and NADPH Oxidase Through Reactive Oxygen Species-Studies in White Blood Cells and in Animal Models
Swenja Kroeller-Schoen et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Cardiovascular Actions of Incretin-Based Therapies
John R. Ussher et al.
CIRCULATION RESEARCH (2014)
Inflammatory Monocytes Determine Endothelial Nitric-oxide Synthase Uncoupling and Nitro-oxidative Stress Induced by Angiotensin II
Sabine Kossmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: Insights from a patient-level pooled analysis of six randomized clinical trials
Vivian A. Fonseca et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation through a Calcium and AMPK Dependent Mechanism
Nadia M. Krasner et al.
PLOS ONE (2014)
Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection
John R. Ussher et al.
MOLECULAR METABOLISM (2014)
A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity
Mohammad Hossein Noyan-Ashraf et al.
CIRCULATION (2013)
The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE-/- mouse model
Tracey Gaspari et al.
DIABETES & VASCULAR DISEASE RESEARCH (2013)
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE(-/-) Mice
Naim Panjwani et al.
ENDOCRINOLOGY (2013)
The State of US Health, 1990-2010 Burden of Diseases, Injuries, and Risk Factors
Christopher J. L. Murray et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure
Minsuk Kim et al.
NATURE MEDICINE (2013)
Exenatide Reduces Final Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction and Short-Duration of Ischemia
Jacob Lonborg et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
Nitroglycerin-Induced Endothelial Dysfunction and Tolerance Involve Adverse Phosphorylation and S-Glutathionylation of Endothelial Nitric Oxide Synthase Beneficial Effects of Therapy With the AT1 Receptor Blocker Telmisartan
Maike Knorr et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Lysozyme M-Positive Monocytes Mediate Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction
Philip Wenzel et al.
CIRCULATION (2011)
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
M. Nagashima et al.
DIABETOLOGIA (2011)
Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
Masayuki Arakawa et al.
DIABETES (2010)
Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes
Juraj Koska et al.
DIABETES CARE (2010)
被撤回的出版物: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells (Retracted article. See vol. 55, pg. 533, 2012)
Y. Hattori et al.
DIABETOLOGIA (2010)
Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells
I. Hadjiyanni et al.
DIABETOLOGIA (2010)
Pentaerythritol Tetranitrate Improves Angiotensin II-Induced Vascular Dysfunction via Induction of Heme Oxygenase-1
Swenja Schuhmacher et al.
HYPERTENSION (2010)
Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor
O. Erdogdu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
S-glutathionylation uncouples eNOS and regulates its cellular and vascular function
Chun-An Chen et al.
NATURE (2010)
Validation of Volume-Pressure Recording Tail-Cuff Blood Pressure Measurements
Minjie Feng et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction
Tomasz J. Guzik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKβ1-/- mice
Matthias Oelze et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
AH Barnett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate
AL Kleschyov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
